Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

Homecompany134678-17-4 98%
Lamivudine
Lamivudine
Lamivudine

134678-17-4 98%

Price Get Latest Price
Packge 1MT1kg5kg10kg25kg
  • Min. Order:1MT
  • Time:2024-02-29

Product Details

  • Product NameLamivudine
  • CAS No.134678-17-4
  • EINECS No.603-844-3
  • MFC8H11N3O3S
  • MW229.26
  • Appearancepowderwhite to beige
  • Melting point 177 °C
  • storage temp. 2-8°C
  • Boiling point 475.4±55.0 °C(Predicted)
  • density 1.73±0.1 g/cm3(Predicted)
  • Water Solubility 70g/L(temperature not stated)

Company Profile Introduction

ShreeGen Pharma Ltd., established in 2013 by highly professional, qualified and experienced personnel from pharma industry.
ShreeGen Pharma Ltd., is a Good Manufacturing Practice [GMP] approved Facility With Strong R & D Technical Team. Complies updated norms of Schedule-M.
We are having a robust growth since we ventured in the manufacturing of Pharmaceutical Active Pharmaceutical Ingredients [API’s], Intermediates and speciality Chemicals.
Working towards strong global presence in pharmaceutical industry.
Supported by well skilled and qualified staff 100+ across the all areas.

ShreeGen Pharma Ltd., established in 2013 by highly professional, qualified and experienced personnel from pharma industry. Shreegen Pharma Ltd., is a Good Manufacturing Practice [GMP] approved Facility With Strong R & D Technical Team. Complies updated norms of Schedule-M.

An Integrated Pharma company with business presence in World Wide. Having all appropriate statutory manufacturing, safety licenses from Government agencies. Prime focus in promoting Anti Retroviral [ARV] drugs. State of art Quality Control laboratory equipped with Instruments such as HPLC’s, GC’s, FT-IR, micro balance.

  • Since:2021-02-01
  • Address: #405, Dasaiah Plaza, Moosapet Kukatpally, Hyderabad, Telangana-500 018, India.
INQUIRY